Your browser doesn't support javascript.
loading
Haemostatic effect of adding tranexamic acid to emicizumab prophylaxis in severe haemophilia A: A preclinical study.
Janbain, Maissa; Enjolras, Nathalie; Bolbos, Radu; Brevet, Marie; Bordet, Jean-Claude; Dargaud, Yesim.
Affiliation
  • Janbain M; Hematology, Tulane School of Medicine, New Orleans, USA.
  • Enjolras N; UR4609 Hemostase & Thrombose, Universite Claude Bernard Lyon 1, Lyon, France.
  • Bolbos R; CERMEP, Centre d'Etude et de Recherche Multimodal Et Pluridisciplinaire, Lyon, France.
  • Brevet M; Cypath, Villeurbanne, France.
  • Bordet JC; UR4609 Hemostase & Thrombose, Universite Claude Bernard Lyon 1, Lyon, France.
  • Dargaud Y; UR4609 Hemostase & Thrombose, Universite Claude Bernard Lyon 1, Lyon, France.
Haemophilia ; 27(6): 1002-1006, 2021 Nov.
Article in En | MEDLINE | ID: mdl-34644431
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tranexamic Acid / Hemostatics / Antibodies, Bispecific / Hemophilia A Limits: Animals / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tranexamic Acid / Hemostatics / Antibodies, Bispecific / Hemophilia A Limits: Animals / Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2021 Type: Article Affiliation country: United States